Login / Signup

The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.

Jacob FredsøeJan KoetsenruijterPeter VedstedPia KirkegaardMichael VæthAdrian EdwardsTorben F ØrntoftKarina Dalsgaard SørensenFlemming Bro
Published in: PLoS medicine (2020)
This study is registered with ClinicalTrials.gov, number NCT01739062.
Keyphrases
  • prostate cancer
  • primary care
  • radical prostatectomy
  • gene expression
  • clinical trial
  • randomized controlled trial